WAPM (World Association of Perinatal Medicine) Working Group on
(2021)
Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection.
Ultrasound Obstet Gynecol, 57 (2).
pp. 232-241.
ISSN 1469-0705
https://doi.org/10.1002/uog.23107
SGUL Authors: Khalil, Asma
Preview |
|
PDF
Accepted Version
Available under License ["licenses_description_publisher" not defined].
Download (1MB)
| Preview
|
Abstract
OBJECTIVES: To evaluate the maternal and perinatal outcomes of pregnancies affected by SARS-CoV-2 infection. METHODS: This was a multinational retrospective cohort study including women with a singleton pregnancy and laboratory-confirmed SARS-CoV-2 infection, conducted in 72 centers in 22 different countries in Europe, the USA, South America, Asia and Australia, between 1 February 2020 and 30 April 2020. Confirmed SARS-CoV-2 infection was defined as a positive result on real-time reverse-transcription polymerase chain reaction (RT-PCR) assay of nasopharyngeal swab specimens. The primary outcome was a composite measure of maternal mortality and morbidity, including admission to the intensive care unit (ICU), use of mechanical ventilation and death. RESULTS: In total, 388 women with a singleton pregnancy tested positive for SARS-CoV-2 on RT-PCR of a nasopharyngeal swab and were included in the study. Composite adverse maternal outcome was observed in 47/388 (12.1%) women; 43 (11.1%) women were admitted to the ICU, 36 (9.3%) required mechanical ventilation and three (0.8%) died. Of the 388 women included in the study, 122 (31.4%) were still pregnant at the time of data analysis. Among the other 266 women, six (19.4% of the 31 women with first-trimester infection) had miscarriage, three (1.1%) had termination of pregnancy, six (2.3%) had stillbirth and 251 (94.4%) delivered a liveborn infant. The rate of preterm birth before 37 weeks' gestation was 26.3% (70/266). Of the 251 liveborn infants, 69/251 (27.5%) were admitted to the neonatal ICU, and there were five (2.0%) neonatal deaths. The overall rate of perinatal death was 4.1% (11/266). Only one (1/251, 0.4%) infant, born to a mother who tested positive during the third trimester, was found to be positive for SARS-CoV-2 on RT-PCR. CONCLUSIONS: SARS-CoV-2 infection in pregnant women is associated with a 0.8% rate of maternal mortality, but an 11.1% rate of admission to the ICU. The risk of vertical transmission seems to be negligible. © 2020 International Society of Ultrasound in Obstetrics and Gynecology.
Item Type: |
Article
|
Additional Information: |
This is the peer reviewed version of the following article: (2021), Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection. Ultrasound Obstet Gynecol, 57: 232-241, which has been published in final form at https://doi.org/10.1002/uog.23107. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages thereof by third parties from platforms, services and websites other than Wiley Online Library must be prohibited. |
Keywords: |
COVID-19, SARS-CoV-2, coronavirus, infection, pregnancy, Adult, COVID-19, Cohort Studies, Female, Hospitalization, Humans, Infant, Infant, Newborn, Intensive Care Units, Maternal Mortality, Pandemics, Pregnancy, Pregnancy Complications, Infectious, Pregnancy Outcome, Respiration, Artificial, Retrospective Studies, SARS-CoV-2, WAPM (World Association of Perinatal Medicine) Working Group on COVID-19, Humans, Pregnancy Complications, Infectious, Pregnancy Outcome, Respiration, Artificial, Hospitalization, Maternal Mortality, Retrospective Studies, Cohort Studies, Pregnancy, Adult, Infant, Infant, Newborn, Intensive Care Units, Female, Pandemics, COVID-19, SARS-CoV-2, coronavirus, COVID-19, infection, pregnancy, SARS-CoV-2, coronavirus, COVID-19, infection, pregnancy, SARS-CoV-2, COVID-19, SARS-CoV-2, coronavirus, infection, pregnancy, Adult, COVID-19, Cohort Studies, Female, Hospitalization, Humans, Infant, Infant, Newborn, Intensive Care Units, Maternal Mortality, Pandemics, Pregnancy, Pregnancy Complications, Infectious, Pregnancy Outcome, Respiration, Artificial, Retrospective Studies, SARS-CoV-2, 1114 Paediatrics and Reproductive Medicine, Obstetrics & Reproductive Medicine |
SGUL Research Institute / Research Centre: |
Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) |
Journal or Publication Title: |
Ultrasound Obstet Gynecol |
ISSN: |
1469-0705 |
Language: |
eng |
Dates: |
Date | Event |
---|
1 February 2021 | Published | 21 January 2021 | Published Online | 26 August 2020 | Accepted |
|
Publisher License: |
Publisher's own licence |
PubMed ID: |
32926494 |
Web of Science ID: |
WOS:000613461600006 |
|
Go to PubMed abstract |
URI: |
https://openaccess.sgul.ac.uk/id/eprint/113682 |
Publisher's version: |
https://doi.org/10.1002/uog.23107 |
Statistics
Item downloaded times since 24 Sep 2021.
Actions (login required)
|
Edit Item |